Krystal Biotech, Inc. (KRYS) NASDAQ
293.21
-4.89(-1.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.14B |
| Enterprise Value | 6.65B |
| P/E Ratio | 38.16 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 20.71 |
| Price/Book Ratio | 6.73 |
| Enterprise/Revenue | 19.52 |
| Enterprise/EBITDA | 43.92 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.54 |
| Operating Margin | 0.43 |
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 389.13M |
| Revenue/Share | 14.25 |
| Gross Profit | 360.36M |
| EBITDA | 167.85M |
| Net Income | 204.83M |
| Diluted EPS | 6.84 |
Balance Sheet
| Total Cash | 823.41M |
| Total Cash/Share | 28.11 |
| Total Debt | 1.8M |
| Total Debt/Equity | 0 |
| Current Ratio | 9.46 |
| Book Value Per Share | 43.59 |
Price History
| 52-Week Change | 133.89 |
| 52-Week High | 319.48 |
| 52-Week Low | 127.99 |
| Moving Average 50 Days | 279.07 |
| Moving Average 200 Days | 233.99 |
Statistics
| Average Volume | 278,806 |
| Shares Outstanding | 29.48M |
| % Held by Institutions | 98 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
